Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Modafinil brands available in india?Darzalex u's patent expiration date?When xyrem offpatent?Verona pharma's ohtuvayre patent?What factors influence tirzepatide's market share vs dulaglutide?
See the DrugPatentWatch profile for keytruda
Keytruda’s FDA approval for melanoma was in 2014.
Keytruda (pembrolizumab) received FDA approval in 2014 for unresectable or metastatic melanoma (with treatment context tied to prior therapy at the time of approval).
Other Questions About Keytruda :